Literature DB >> 7041815

Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.

S G Amyes.   

Abstract

The combined effects of trimethoprim and sulfamethoxazole on the viability of Escherichia coli K-12 and resistant strains possessing resistance plasmids were examined in minimal medium. When methionine, glycine, and adenine were present, sulfamethoxazole could enhance trimethoprim activity against E. coli K-12 so that the combination was bactericidal. However, this enhancement occurred over a narrow range of trimethoprim concentrations (0.04 to 0.2 mg liter-1) and only when the sulfamethoxazole concentration was more than 10 times that of trimethoprim. Under certain conditions, sulfamethoxazole enhanced trimethoprim bactericidal activity against E. coli K-12 carrying plasmid R1 at concentrations of sulfamethoxazole far below those required to inhibit the organism, but there was no such enhancement with the same host containing the SSu plasmid. Similar differences were found with strains possessing trimethoprim resistance plasmids R483 and R751. Sulfamethoxazole can promote a bactericidal response with trimethoprim in E. coli K-12 and some of its resistant derivatives, but only under a narrow range of concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041815      PMCID: PMC181875          DOI: 10.1128/AAC.21.2.288

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

2.  R-factor mediated dihydrofolate reductases which confer trimethoprim resistance.

Authors:  S G Amyes; J T Smith
Journal:  J Gen Microbiol       Date:  1978-08

3.  The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo--I. Action of sulfonamides and trimethoprim in blood and urine.

Authors:  R Then; P Angehrn
Journal:  Biochem Pharmacol       Date:  1974-11-01       Impact factor: 5.858

4.  Comparison of long-term, low-dosage nitrofurantoin, methenamine hippurate, trimethoprim and trimethoprim-sulphamethoxazole on the control of recurrent urinary tract infection.

Authors:  A Kasanen; E Kaarsalo; R Hiltunen; V Soini
Journal:  Ann Clin Res       Date:  1974-10

5.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

6.  The relation of resistance transfer factors to the F-factor (sex-factor) of Escherichia coli K12.

Authors:  E Meynell; N Datta
Journal:  Genet Res       Date:  1966-02       Impact factor: 1.588

7.  Mechanisms and distribution of bacterial resistance to diaminopyrimidines and sulphonamides.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

8.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

9.  Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.

Authors:  J D Anderson; R W Lacey; E L Lewis; M A Sellin
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

10.  Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance.

Authors:  R W Lacey; V L Lord; H K Gunasekera; P J Leiberman; D E Luxton
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

View more
  2 in total

1.  Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.

Authors:  Kishore Viswanathan; Kathleen M Frey; Eric W Scocchera; Brooke D Martin; P Whitney Swain Iii; Jeremy B Alverson; Nigel D Priestley; Amy C Anderson; Dennis L Wright
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 2.  Proximate and ultimate causes of the bactericidal action of antibiotics.

Authors:  Fernando Baquero; Bruce R Levin
Journal:  Nat Rev Microbiol       Date:  2020-10-06       Impact factor: 60.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.